168 related articles for article (PubMed ID: 10504505)
1. Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy.
Berg AL; Nilsson-Ehle P; Arnadottir M
Kidney Int; 1999 Oct; 56(4):1534-43. PubMed ID: 10504505
[TBL] [Abstract][Full Text] [Related]
2. Effects of different doses of adrenocorticotrophic hormone on the serum lipoprotein profile in healthy subjects.
Rafnsson AT; Johannsson M; Olafsson I; Dallongeville J; Erfurth EM; Berg AL; Arnadottir M
Basic Clin Pharmacol Toxicol; 2005 Aug; 97(2):86-90. PubMed ID: 15998354
[TBL] [Abstract][Full Text] [Related]
3. A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar® Gel) in nephrotic syndrome due to idiopathic membranous nephropathy.
Hladunewich MA; Cattran D; Beck LH; Odutayo A; Sethi S; Ayalon R; Leung N; Reich H; Fervenza FC
Nephrol Dial Transplant; 2014 Aug; 29(8):1570-7. PubMed ID: 24714414
[TBL] [Abstract][Full Text] [Related]
4. The effects of adrenocorticotrophic hormone and an equivalent dose of cortisol on the serum concentrations of lipids, lipoproteins, and apolipoproteins.
Berg AL; Rafnsson AT; Johannsson M; Dallongeville J; Arnadottir M
Metabolism; 2006 Aug; 55(8):1083-7. PubMed ID: 16839845
[TBL] [Abstract][Full Text] [Related]
5. Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial.
Bomback AS; Canetta PA; Beck LH; Ayalon R; Radhakrishnan J; Appel GB
Am J Nephrol; 2012; 36(1):58-67. PubMed ID: 22722778
[TBL] [Abstract][Full Text] [Related]
6. Short-term administration of ACTH improves plasma lipid profile and renal function in kidney transplant patients.
He X; Xue P; Xu X; Luo G; Zhou G; Nilsson-Ehle P; Xu N
Transplant Proc; 2006 Jun; 38(5):1371-4. PubMed ID: 16797307
[TBL] [Abstract][Full Text] [Related]
7. Effects of short-term treatment with corticotropin on the serum apolipoprotein pattern.
Arnadottir M; Dallongeville J; Nilsson-Ehle P; Berg AL
Scand J Clin Lab Invest; 2001 Jul; 61(4):301-6. PubMed ID: 11465344
[TBL] [Abstract][Full Text] [Related]
8. LDL-apheresis in patients with nephrotic syndrome: effects on serum albumin and urinary albumin excretion.
Stenvinkel P; Alvestrand A; Angelin B; Eriksson M
Eur J Clin Invest; 2000 Oct; 30(10):866-70. PubMed ID: 11029600
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol metabolism in glomerular cells: effect of lipoproteins from nephrotic patients.
Wanner C; Krämer-Guth A; Nauck M; Quaschning T; Pavenstädt H; Schollmeyer P
Miner Electrolyte Metab; 1996; 22(1-3):39-46. PubMed ID: 8676822
[TBL] [Abstract][Full Text] [Related]
10. Plasma total homocysteine concentration in nephrotic patients with idiopathic membranous nephropathy.
Arnadottir M; Hultberg B; Berg AL
Nephrol Dial Transplant; 2001 Jan; 16(1):45-7. PubMed ID: 11208992
[TBL] [Abstract][Full Text] [Related]
11. Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel.
Bomback AS; Tumlin JA; Baranski J; Bourdeau JE; Besarab A; Appel AS; Radhakrishnan J; Appel GB
Drug Des Devel Ther; 2011 Mar; 5():147-53. PubMed ID: 21448451
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome.
Kosmadakis G; Filiopoulos V; Georgoulias C; Tentolouris N; Michail S
Scand J Urol Nephrol; 2010 Sep; 44(4):251-6. PubMed ID: 20201749
[TBL] [Abstract][Full Text] [Related]
13. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?
Muso E; Yashiro M; Matsushima M; Yoshida H; Sawanishi K; Sasayama S
Nephrol Dial Transplant; 1994; 9(3):257-64. PubMed ID: 8052431
[TBL] [Abstract][Full Text] [Related]
14. Case series of idiopathic membranous nephropathy with long-term beneficial effects of ACTH peptide 1-24.
Rauen T; Michaelis A; Floege J; Mertens PR
Clin Nephrol; 2009 Jun; 71(6):637-42. PubMed ID: 19473632
[TBL] [Abstract][Full Text] [Related]
15. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
[TBL] [Abstract][Full Text] [Related]
16. Treatment of nephrotic hyperlipoproteinemia with gemfibrozil.
Groggel GC; Cheung AK; Ellis-Benigni K; Wilson DE
Kidney Int; 1989 Aug; 36(2):266-71. PubMed ID: 2779095
[TBL] [Abstract][Full Text] [Related]
17. High-density lipoproteins in untreated idiopathic nephrotic syndrome without renal failure.
Joven J; Rubiés-Prat J; Espinel E; Ras MR; Piera L
Nephrol Dial Transplant; 1987; 2(3):149-53. PubMed ID: 3114674
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of apoproteins A and B, lipoproteins and plasma lipids during treatment with bezafibrate in various forms of hyperlipoproteinemia].
Saitta A; Bonaiuto M; Lanzafame F; Mileto A; Pernice F; Cinquegrani M; Mazza G; Micali G; Pangallo A; Fodale P
Clin Ter; 1988 Mar; 124(5):373-81. PubMed ID: 2974348
[No Abstract] [Full Text] [Related]
19. Angiotensin II antagonism improves the lipoprotein profile in patients with nephrotic syndrome.
de Zeeuw D; Gansevoort RT; Dullaart RP; de Jong PE
J Hypertens Suppl; 1995 Jul; 13(1):S53-8. PubMed ID: 18800457
[TBL] [Abstract][Full Text] [Related]
20. Plasma lipids and lipoprotein-cholesterol distribution in nephrotic syndrome patients during short term high dose steroid treatment.
Arije A; Erasmus RT; Anjorin SA
Cent Afr J Med; 1993 Oct; 39(10):211-5. PubMed ID: 8020077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
